IRIS PubliCatt

Morganti, Alessio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.920
NA - Nord America 6.328
AS - Asia 1.203
AF - Africa 73
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 13
Totale 14.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.238
DE - Germania 3.104
SE - Svezia 1.263
CN - Cina 804
UA - Ucraina 627
IT - Italia 527
IE - Irlanda 329
FR - Francia 285
GB - Regno Unito 244
FI - Finlandia 172
IN - India 155
PL - Polonia 148
TR - Turchia 103
CA - Canada 85
CI - Costa d'Avorio 65
BE - Belgio 62
CZ - Repubblica Ceca 38
JP - Giappone 33
RU - Federazione Russa 33
IR - Iran 32
HK - Hong Kong 24
NL - Olanda 24
VN - Vietnam 16
SG - Singapore 13
EU - Europa 12
AU - Australia 11
RO - Romania 11
ES - Italia 10
CH - Svizzera 7
CL - Cile 7
EG - Egitto 6
PT - Portogallo 6
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
GR - Grecia 4
IL - Israele 4
AR - Argentina 3
BR - Brasile 3
DK - Danimarca 3
HU - Ungheria 3
LK - Sri Lanka 3
MY - Malesia 3
PE - Perù 3
RS - Serbia 3
A1 - Anonimo 2
EC - Ecuador 2
HR - Croazia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
BD - Bangladesh 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
ID - Indonesia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 14.574
Salva come PNG Salva come JPEG
Città #
Chandler 1.538
Ashburn 494
Jacksonville 385
Dublin 327
San Mateo 310
Nanjing 230
Dearborn 216
Ann Arbor 215
Wilmington 192
Nürnberg 183
Woodbridge 153
New York 149
Boston 147
Warsaw 145
Bremen 127
Milan 127
Marseille 118
Lawrence 103
Izmir 101
Beijing 95
Nanchang 92
Cattolica 89
Princeton 85
Houston 80
Fairfield 77
Redwood City 71
Abidjan 65
Brussels 62
Leawood 61
Seattle 60
Helsinki 52
Rome 49
Zhengzhou 44
North York 42
Munich 40
University Park 39
Kunming 37
Hebei 36
Shenyang 36
Jiaxing 35
Los Angeles 35
Augusta 34
Boardman 34
Fremont 32
Toronto 32
Changsha 29
Tianjin 29
Phoenixville 28
Cambridge 27
Mountain View 26
Norwalk 26
Detroit 24
Lancaster 24
Auburn Hills 23
Hangzhou 21
Pune 21
Washington 19
Falls Church 18
Guangzhou 17
Redmond 16
Hanoi 15
Monmouth Junction 15
Shanghai 15
Amsterdam 13
Edinburgh 13
Lanzhou 13
Enterprise 12
Hong Kong 12
Andover 11
Hefei 11
Jinan 11
Ardabil 9
Chicago 9
Indiana 9
San Francisco 9
Dresden 8
Sacramento 8
Bari 7
Brno 7
Central District 7
Costa Mesa 7
Ningbo 7
Sergii 7
Simi Valley 7
Singapore 7
Tokyo 7
Wuhan 7
Arezzo 6
Berlin 6
Kish 6
Landshut 6
London 6
Mumbai 6
Phoenix 6
Bologna 5
Chengdu 5
Saint Paul 5
Turin 5
Zanjan 5
Albuquerque 4
Totale 7.356
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 789
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 249
A National project for in vivo dosimetry procedures in radiotherapy: First results 241
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 222
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 164
A National project for in vivo dosimetry procedures in radiotherapy: First results 160
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 157
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 156
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 156
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 141
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 138
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 135
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 132
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 131
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 131
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 130
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 128
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 127
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 125
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 124
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 122
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 122
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 121
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 121
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 119
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 118
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 118
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 118
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 118
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 118
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 116
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 115
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 113
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 112
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 110
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 108
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 107
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 106
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 105
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 105
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 104
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 104
In Vivo Portal Dosimetry by an Ionization Chamber 103
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 103
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 103
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 102
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 101
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 101
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 98
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 97
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 97
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 97
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 97
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 96
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 94
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 94
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 92
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 92
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 90
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 89
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 89
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 89
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 89
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 88
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 87
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 87
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 86
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 85
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 84
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 84
Real time transit dosimetry for the breath-hold radiotherapy technique experience 83
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 83
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 82
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 82
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 80
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 79
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 79
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 79
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 78
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 78
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 78
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 78
Preoperative chemoradiation with raltitrexed (Tomudex) in T2/N+ and T3/N+ rectal cancers: a phase I study. 77
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 76
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 76
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 76
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 75
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 74
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 74
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 73
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 72
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 72
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 70
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 70
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 70
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 69
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 68
Totale 11.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019286 0 0 0 0 0 0 0 0 0 0 183 103
2019/20202.392 361 145 106 99 217 223 298 136 216 163 265 163
2020/20211.452 81 171 30 156 204 64 140 42 167 107 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.413 66 532 83 149 44 231 103 137 18 49 1 0
Totale 15.247